These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 10585273

  • 1. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M.
    Exp Cell Res; 1999 Dec 15; 253(2):503-10. PubMed ID: 10585273
    [Abstract] [Full Text] [Related]

  • 2. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH, Drullinger LF, Soulard A, Dulić V.
    Mol Cell Biol; 1999 Mar 15; 19(3):2109-17. PubMed ID: 10022898
    [Abstract] [Full Text] [Related]

  • 3. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.
    Mol Cell Biol; 2001 Feb 15; 21(3):794-810. PubMed ID: 11154267
    [Abstract] [Full Text] [Related]

  • 4. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 5. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G.
    Mol Cell Biol; 1999 Mar 09; 19(3):1981-9. PubMed ID: 10022885
    [Abstract] [Full Text] [Related]

  • 6. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O.
    Hepatology; 1999 Feb 09; 29(2):385-95. PubMed ID: 9918914
    [Abstract] [Full Text] [Related]

  • 7. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS.
    Oncogene; 1998 Apr 23; 16(16):2141-50. PubMed ID: 9572495
    [Abstract] [Full Text] [Related]

  • 8. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 9. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
    Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC.
    Proc Natl Acad Sci U S A; 1996 Nov 26; 93(24):13742-7. PubMed ID: 8943005
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of cyclin-dependent kinase inactivation by progestins.
    Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL.
    Mol Cell Biol; 1998 Apr 26; 18(4):1812-25. PubMed ID: 9528753
    [Abstract] [Full Text] [Related]

  • 11. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 12. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.
    Jiang H, Chou HS, Zhu L.
    Mol Cell Biol; 1998 Sep 18; 18(9):5284-90. PubMed ID: 9710613
    [Abstract] [Full Text] [Related]

  • 13. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
    Albrecht JH, Rieland BM, Nelsen CJ, Ahonen CL.
    Am J Physiol; 1999 Dec 18; 277(6):G1207-16. PubMed ID: 10600818
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.
    Blood; 2000 Oct 15; 96(8):2746-54. PubMed ID: 11023508
    [Abstract] [Full Text] [Related]

  • 15. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW, Montalvo E, Massagué J.
    J Biol Chem; 1997 Oct 10; 272(41):25863-72. PubMed ID: 9325318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).
    Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH.
    Mol Cell Biol; 1999 May 10; 19(5):3916-28. PubMed ID: 10207115
    [Abstract] [Full Text] [Related]

  • 20. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C, Pratt MA.
    Mol Endocrinol; 1997 Aug 10; 11(9):1191-202. PubMed ID: 9259311
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.